SCHEMBL4140079

SCHEMBL4140079

Fc1c(F)c(F)c(-c2ccccn2)c(F)c1F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.62
LMNA P02545 3/20 0.62
CCR1 P32246 3/20 0.62
CCR5 P51681 3/20 0.62
CCR8 P51685 3/20 0.62
CYP1A2 P05177 1/20 0.62
POLB P06746 1/20 0.62
METAP1 P53582 1/20 0.62
BLM P54132 1/20 0.62
HIF1A Q16665 1/20 0.62
DOHH Q9BU89 1/20 0.62
P4HTM Q9NXG6 1/20 0.62
NPC1 O15118 6/20 0.52
RAB9A P51151 4/20 0.52
TP53 P04637 4/20 0.52
ALOX15 P16050 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
HTT P42858 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31568869 1.00 KDM4E (0.62) KDM4ELMNACCR1CCR5CCR8
SCHEMBL12405055 0.85 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL28180497 0.84 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL21988535 0.83 KDM4E (0.48) KDM4ELMNACCR1CCR5CCR8
SCHEMBL31400283 0.83 KDM4E (0.48) KDM4ELMNACCR1CCR5CCR8
SCHEMBL25992024 0.82 KDM4E (0.52) KDM4ELMNACCR1CCR5CCR8
SCHEMBL1641109 0.82 KDM4E (0.52) KDM4ELMNACCR1CCR5CCR8
SCHEMBL23629598 0.82 KDM4E (0.46) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL202129 0.81 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
SCHEMBL11910164 0.81 KDM4E (0.81) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250136629-A1 SELF-ASSEMBLED NANOPARTICLES FOR PHOTOTHERMAL THERAPY Laboratory for Synthetic Chemistry and Chemical Biology Limited (CN) 2025-05-01 US disclosed
US-8952207-B2 Copper-catalyzed C—H bond arylation THE UNIVERSITY OF HOUSTON SYSTEM (US) 2015-02-10 US disclosed
US-20100213443-A1 Oled devices BATTELLE MEMORIAL INSTITUTE 2010-08-26 US disclosed
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250136629-A1 SELF-ASSEMBLED NANOPARTICLES FOR PHOTOTHERMAL THERAPY TFRC, ALB, HSPA8 KDM4E 4353/4885LMNA 3734/4885CCR1 4098/4885
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION AOC2, AOC3, DBH KDM4E 4036/4885LMNA 4869/4885CCR1 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.